Bedfont® Scientific Limited Triumphs at Chamber Business Awards, Winning Business of the Year 2024

Best practices in RF ablation yield excellent outcomes for atrial fibrillation patients

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone.

May 20, 2024

Skyline wins orphan drug designation for retinitis pigmentosa gene therapy – Pharmaceutical Technology

Retinitis pigmentosa can eventually lead to complete blindness. Credit: GBJSTOCK via Shutterstock. Gene therapy company Skyline Therapeutics has secured an orphan drug designation from the

September 3, 2024

Aceragen to pull out of Nasdaq and liquidate assets, ending tumultuous journey for Idera Pharma

Aceragen is set to cease its Nasdaq listing, the next step for the beleaguered company whose assets are slated to be liquidated. The company has

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.